MentionFox
Home › Layoffs › KALA BIO, Inc.
SEC filings · Form 8-K, Item 2.05

KALA BIO, Inc. layoffs and restructuring

Before you join, sell to or invest in KALA BIO, Inc.

MentionFox check on KALA BIO, Inc.: no red flags found in 3 sources; 1 item to note (checked 7 November 2026). mentionfox.com/c/layoffs/kala-bio

  • Note: Layoff plan disclosed Oct 2025 (filing)

Check KALA BIO, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about KALA BIO, Inc.?

Every exit or restructuring plan KALA BIO, Inc. reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

As of November 7, 2026, KALA BIO, Inc. has reported 3 exit or restructuring plans to the SEC on Form 8-K under Item 2.05, the latest filed on October 20, 2025. KALA BIO, Inc. trades on Nasdaq as KALA. No WARN notice under its name is on file in the states covered here (Form 8-K, October 20, 2025).

12 companies announced layoffs this week.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

Artiva Biotherapeutics, Inc.announced layoffs
Eos Energy Enterprises, Inc.announced layoffs
SOUNDHOUND AI, INC.announced layoffs
Portillo's Inc.announced layoffs
Acumen Pharmaceuticals, Inc.announced layoffs of about 52 employees
Check one company free

SR One Capital Fund II Aggregator, LP also filed stake reports on 6 other companies ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of KALA BIO, Inc.

Watch KALA BIO, Inc.: email me the next time it files something

Free to see. No signup.

SEC filings3
Latest filing2025-10-20

KALA BIO, Inc. reported 3 exit or restructuring plans on Form 8-K under Item 2.05, 2 of 3 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did KALA BIO have layoffs in 2025? What its filings say

KALA BIO, Inc. (CIK 1479419) reported 3 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K filed 2025-10-20

This filing reports Item 2.05, and its section states none of employees affected, share of workforce, locations, charges or timing in a single sentence. The full text is in the filing.

Open the filing

Form 8-K/A filed 2025-10-02

Employees affected

In connection with such decisions, the Board approved a reduction in the Company's workforce by approximately 19 employees, or approximately 51% (the "Reduction").

Expected charges

Subsequent to the Original Report, the Company determined that it expects to incur costs of approximately $0.4 million related to the Reduction, primarily consisting of severance payments and employee benefit costs.

Timing

The costs related to the Reduction are expected to be substantially incurred in the fourth quarter of 2025.

Open the filing

Form 8-K filed 2025-09-29

Employees affected

In connection with such decisions, the Board approved a reduction in the Company's workforce by approximately 19 employees, or approximately 51% (the "Reduction").

Timing

The Company expects to substantially complete the Reduction in the fourth quarter of 2025.

Open the filing

KALA BIO, Inc.: every filing and event

Also on the record for KALA BIO, Inc.

DateRecordFigureOur pageSource
October 19, 2026Stake report, Schedule 13G, by Labkowski Nachum5% of the class5%+ stakesSource
July 2, 2026Stake report, Schedule 13D/A, by Lazar David E.3.9% of the class5%+ stakesSource
May 15, 2026Stake report, Schedule 13G/A, by Baker Bros. Advisors LP0.01% of the class5%+ stakesSource
March 17, 2026Form D, private offering$1.75M soldForm D pageSource
February 17, 2026Stake report, Schedule 13G/A, by Baker Bros. Advisors LP9.99% of the class5%+ stakesSource
February 13, 2026Form D, private offering$2.25M soldForm D pageSource
February 6, 2026Stake report, Schedule 13D, by David E. Lazar5.18% of the class5%+ stakesSource
January 13, 2026Stake report, Schedule 13G, by LifeSci Capital LLC7.9% of the class5%+ stakesSource
December 3, 2025Stake report, Schedule 13G, by OXFORD FINANCE LLC16.5% of the class5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by Cormorant Asset Management, LP—5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by Perceptive Advisors LLC—5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by Point72 Asset Management, L.P.—5%+ stakesSource

Keep reading

More on KALA BIO, Inc. and the records around it.

KALA BIO, Inc. elsewhere on the record

Companies that share a holder

What do you want to do with KALA BIO, Inc.?

Want the whole picture on KALA BIO, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on KALA BIO, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on KALA BIO, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    15 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 19 records.

See all on KALA BIO, Inc.'s page

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for KALA BIO, Inc.. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

All recent layoffsThat week

Who owns KALA BIO, Inc.? Owners, funding and legal record

Cite this page

Permanent URL: https://mentionfox.com/layoffs/kala-bio
Last updated 2026-11-07
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
KALA BIO, Inc. layoffs and restructuring: 3 SEC filings (2025-10-20). MentionFox, 2026-11-07. https://mentionfox.com/layoffs/kala-bio